Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

top_ten_1

Top Ten most popular articles on Pharmafile.com this week

July 7, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing most read articles, most read news, top ten

It’s Friday, and we’ve brought together our weekly digest of the articles which proved most popular with our readers. Brexit …
News
merck_entrance

FDA shutters MSD’s Keytruda combination trials in myeloma

July 6, 2017 Medical Communications, Research and Development MSD, immunotherapy, keytruda, pd-1

Following on from the news last month that enrolment for Keytruda being used alongside Celgene’s Imnovid and Revlimid would have …
News
tau_tangle

Atomic structure of tau revealed opening up new Alzheimer’s targets

July 6, 2017 Research and Development Alzheimer's disease, dementia, tau protein, tau tangle

It is a research breakthrough that has been touted as the biggest development in Alzheimer’s disease research for a quarter …
News
cancer_cells

Breakthrough in personalised medicine as cancer vaccine shows results

July 6, 2017 Research and Development Precision Medicine, personalised medicine, precision oncology

The old adage that everyone is unique holds a lot of water when it comes to cancer treatment. Research has …
News

Merck Foundation created and CEO set in place

July 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck Foundation, Merck KGaA

Merck KGaA announced that is has created the Merck Foundation and has appointed Rasha Kelej as its CEO. The role …
Appointment
eu_and_fda

EMA and FDA harmonise over development of Gaucher drugs

July 5, 2017 Medical Communications, Research and Development, Sales and Marketing EMA, FDA, Gaucher disease

The EMA and the FDA have announced that they have developed a joint proposal to promote more efficient means of …
News

NICE agrees approval deal for ultra-rare juvenile bone disease

July 5, 2017 Research and Development, Sales and Marketing Alexion, NICE, Strensiq

NICE has announced that it has decided to approve Alexion Pharma’s Strensiq (asfotase alfa) for the treatment of ultra-rare disease …
News
8384110298_da510e0347_c

Google’s DeepMind app deal with NHS brought into question

July 5, 2017 Medical Communications, Research and Development Alphabet, DeepMind, NHS, google

DeepMind’s deal with the NHS to develop an app that is able to detect possible kidney damage involved 1.6 million …
News
shutterstock_159488225

Tumour genome mapping could lead to improved outcomes, research finds

July 5, 2017 Research and Development Cancer, Hi-C

A research team at the Babraham Institute in Cambridge, UK has revealed a new method to detect and monitor large-scale …
News
new_wave_logo_cmyk

Gain insight into what your peers are doing

July 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, wave

When they first came along, webinars were the equivalent of an outside broadcast unit, lots of hardware, dedicated studios and …
Feature
shutterstock_38078521

Researchers boost existing antibiotic to tackle drug resistance

July 4, 2017 Research and Development University of Lincoln, antibiotic resistance

The growing issue of antibiotic resistance is finding itself increasingly central in pharma’s priorities, though many still argue that the …
News
shutterstock_146497481

Top CMO pushes for routine genome screening on NHS

July 4, 2017 Manufacturing and Production, Research and Development NHS, genome sequencing

England’s top Chief Medical Officer has called for routine DNA testing to become standard on the NHS in a bid …
News

Forging a path forward in neurological disorders

July 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing neurological disorders

The development of innovative treatments for neurological disorders such as dementia has stagnated over the past decade despite being an …
Feature
index_ph001

Big success and even bigger failure for Daiichi Sankyo’s experimental therapy

July 3, 2017 Research and Development, Sales and Marketing Daiichi Sankyo, mirogabalin

Daiichi Sankyo has been hit with mixed news this week regarding its experimental therapy mirogabalin. The drug posted trial success …
News
gsk_boronia_australia

GSK signs $43 million AI-based drug discovery deal with Exscientia

July 3, 2017 Research and Development, Sales and Marketing AstraZeneca, Exscientia, GSK

With AI partnerships becoming increasingly common in the life sciences industry, it has emerged that GSK is to partner up …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025